Recent 52-Week High Exceeded in Shares of NuVasive (NUVA)
Shares of NuVasive (NASDAQ:NUVA) traded at a new 52-week high today of $64.59. Approximately 89,000 shares have changed hands today, as compared to an average 30-day volume of 754,000 shares.
NuVasive (NASDAQ:NUVA) is currently priced 9.2% above its average consensus analyst price target of $58.47. The stock should discover initial support at its 200-day moving average (MA) of $49.69 and subsequent support at its 50-day MA of $48.04.
NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
Over the past year, NuVasive has traded in a range of $36.81 to $64.59 and is now at $64.42, 75% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.2% while the 200-day MA has remained constant.
SmarTrend recommended that subscribers consider buying shares of NuVasive on March 4th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $43.48. Since that recommendation, shares of NuVasive have risen 46.1%. We continue to monitor NUVA for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows nuvasive